Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fabbrocini

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Journal of Investigational Allergology & Clinical Immunology|May 8, 2020
A Multicenter Study on the Prevalence of Clinical Patterns and Clinical Phenotypes in Adult Atopic DermatitisE Nettis, M Ortoncelli, G Pellacani, et al.
The British Journal of Dermatology|March 3, 2020
Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort studyA V Marzano, G Genovese, G Casazza, et al.
Journal of Investigational Allergology & Clinical Immunology|August 29, 2020
Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective StudyE Nettis, S M Ferrucci, M Ortoncelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 17, 2014
Fragility of epidermis and its consequence in dermatologyJ F Stalder, D Tennstedt, M Deleuran, et al.
The British Journal of Dermatology|September 30, 2020
Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patientsE Nettis, G Fabbrocini, M Ortoncelli, et al.
Archives of Dermatological Research|June 8, 2021
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter studyA Campanati, T Bianchelli, R Gesuita, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2023
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS)L Gargiulo, L Ibba, P Malagoli, et al.
Archives of Dermatological Research|July 8, 2021
Correction to: Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter studyA Campanati, T Bianchelli, R Gesuita, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 12, 2019
HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativaK Peris, A Lo Schiavo, G Fabbrocini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 17, 2020
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life studyC Patruno, M Napolitano, G Argenziano, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Journal of Investigational Allergology & Clinical Immunology|May 8, 2020
A Multicenter Study on the Prevalence of Clinical Patterns and Clinical Phenotypes in Adult Atopic DermatitisE Nettis, M Ortoncelli, G Pellacani, et al.
The British Journal of Dermatology|March 3, 2020
Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort studyA V Marzano, G Genovese, G Casazza, et al.
Journal of Investigational Allergology & Clinical Immunology|August 29, 2020
Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective StudyE Nettis, S M Ferrucci, M Ortoncelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 17, 2014
Fragility of epidermis and its consequence in dermatologyJ F Stalder, D Tennstedt, M Deleuran, et al.
The British Journal of Dermatology|September 30, 2020
Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patientsE Nettis, G Fabbrocini, M Ortoncelli, et al.
Archives of Dermatological Research|June 8, 2021
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter studyA Campanati, T Bianchelli, R Gesuita, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2023
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS)L Gargiulo, L Ibba, P Malagoli, et al.
Archives of Dermatological Research|July 8, 2021
Correction to: Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter studyA Campanati, T Bianchelli, R Gesuita, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 12, 2019
HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativaK Peris, A Lo Schiavo, G Fabbrocini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 17, 2020
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life studyC Patruno, M Napolitano, G Argenziano, et al.
Pageof 14